Needham Reiterates Buy Rating on OncoCyte Corp (OCX) May 13, 2025 06:44AM
Oncocyte Reports Q1 2025 Results and Business Progress May 12, 2025 04:05PM
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference Apr 2, 2025 08:45AM
Needham Reiterates Buy Rating on OncoCyte Corp (OCX) Mar 25, 2025 06:29AM
OncoCyte (OCX) prices $29.1 million equity offering at $2.05 per share Feb 10, 2025 08:31AM


Feb 10, 2025 08:30AM Oncocyte Prices $29.1 Million Equity Offering
Nov 13, 2024 06:34AM Needham Reiterates Buy Rating on OncoCyte Corp (OCX)
Oct 15, 2024 06:11AM Needham Reiterates Buy Rating on OncoCyte Corp (OCX)
Oct 3, 2024 06:04AM OncoCyte (OCX) Announces 3.46M Share Offering at $2.95/sh
Oct 2, 2024 06:35PM Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Aug 5, 2024 04:05PM Oncocyte Announces August Investor Conferences Participation
Apr 24, 2024 10:38AM OncoCyte Corp (OCX) PT Raised to $4.25 at Needham
Apr 12, 2024 06:07AM OncoCyte (OCX) Enters Securities Purchase Agreement
Apr 11, 2024 09:46PM Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Aug 8, 2023 08:30AM Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
Aug 3, 2022 04:01PM Oncocyte to Participate at Upcoming Investor Conferences
Apr 14, 2022 05:35AM OncoCyte (OCX) Prices 26.27M Share Offering at $1.33/sh
Apr 13, 2022 10:01PM Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants
Apr 13, 2022 05:12PM OncoCyte (OCX) Announces Proposed Public Offering of Common Stock and Warrants
Apr 13, 2022 05:12PM Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants
Mar 11, 2022 06:31AM OncoCyte Corp (OCX) PT Lowered to $4 at Needham & Company
Dec 15, 2021 01:25PM OncoCyte Corp (OCX) PT Lowered to $5 at Needham & Company
Nov 10, 2021 06:24AM OncoCyte Corp (OCX) PT Lowered to $7 at Needham & Company
Aug 9, 2021 08:00AM Oncocyte to Participate in Upcoming Investor Events
Apr 6, 2021 04:05PM Oncocyte to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference
Mar 17, 2021 07:14AM Needham & Company Assumes OncoCyte Corp (OCX) at Buy
Feb 9, 2021 04:05PM Oncocyte Announces Closing of $40 Million Public Offering of Common Stock
Feb 5, 2021 08:27AM OncoCyte (OCX) Prices $35 Million Public Offering of Common Stock at $4.50/sh
Feb 5, 2021 08:25AM Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock
Feb 4, 2021 04:08PM OncoCyte (OCX) to Offer Common Stock
Feb 4, 2021 04:05PM Oncocyte Announces Proposed Public Offering of Common Stock
Jan 12, 2021 06:21PM Oncocyte to Present at the 23rd Annual Needham Virtual Growth Conference
Nov 13, 2020 07:37AM OncoCyte Corp (OCX) PT Raised to $4 at Needham & Company
Aug 13, 2020 04:05PM Oncocyte to Participate at Needham Virtual Cancer Diagnostics Conference
Jun 2, 2020 05:35AM Needham & Company Starts OncoCyte Corp (OCX) at Buy
Apr 7, 2020 08:00AM Oncocyte to Participate at 19th Annual Needham Virtual Healthcare Conference